HIGH SPRINGS, FL--(Marketwire - June 12, 2009) -
CTD Holdings, Inc. (OTCBB:
CTDH)
(FRANKFURT: CDJ) announced that ViStra Growth Partners, Inc. (VGP), the
newly created subsidiary of CTD, has agreed to present a preliminary
project plan to the CTD board of directors by year end, 2009, for the
proposed "Joszef Szejtli Cyclodextrin Research Park." Mr. Louis Weltman,
the President/CEO of VGP, has considerable experience with commercial
property development for such purposes. Rick Strattan, the Chairman/CEO of
CTDH, stated that, "This project has been on the back burner at CTDH ever
since we paid off the mortgage on the 40 acre corporate site in 2007. The
convergence of CTDH's work with Chris Hempel to get Trappsol® HPB into a
compassionate use study for her twin girls with Niemann-Pick disease, a
form of childhood Alzheimer's, and working with the expertise of Lou
Weltman and his knowledge of 501(c)3 organizations has really crystallized
for me what the mission of the Research Park will be."
Mr. Strattan continues, "Chris Hempel has done more in the last 18 months
to introduce the worldwide public and regulatory agencies to the amazing
properties of Cyclodextrins, than the entire industry has been able to do
in the last 20 years."
Ms. Hempel's exploits, efforts and successes are available on the web at
www.addiandcassi.com and www.webofhope.com.
About CTD Holdings, Inc.
The company is the one-stop shop, business to business facilitator of
commercial and research applications of cyclodextrins. With its branded
Trappsol® and Aquaplex® product offerings, CTDH scientists coordinate
the development of commercial products for use in the pharmaceuticals,
foods, hazardous waste treatment, and cosmetics industries, just to name a
few of the industries which endeavor to put non water-soluble ingredients
into water-based formulations. More recently CTDH has worked, in an
advisory capacity, on the benefits and application of Cyclodextrins as a
treatment for Niemann-Pick disease, a debilitating childhood disease often
associated with Alzheimer's. CTDH was founded in 1990 as a Florida
corporation and became a public company in 1994. Additional information on
the Company can be found on the Company's website: www.cyclodex.com
This news release contains "forward-looking statements" that are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. You are cautioned that such statements are subject to
risks and uncertainties that could cause future circumstances, events or
results to differ materially from those projected in the forward-looking
statements. CTDH complies with the regulations and time lines mandated by
the SEC in the filing of its financial reports; these filings also contain
forward-looking statements. The above forward-looking statements are made
as of the date above; CTD Holdings, Inc. accepts no specific responsibility
for updating such statements.
